发明名称 Active protease-resistant antibody FC mutants
摘要 The present invention relates to modified Fc-containing molecules including modified antibodies characterized by increased resistance to host and pathogen-derived proteases, ability to interact with FcγR receptors except with FcγRI, and lack of induction of IL-10 secretion by macrophages, and methods of using and making them.
申请公布号 US8871204(B2) 申请公布日期 2014.10.28
申请号 US201213555334 申请日期 2012.07.23
申请人 Janssen Biotech, Inc. 发明人 Brezski Randall;Jordan Robert;Strohl William
分类号 A61K38/00;C07K16/00 主分类号 A61K38/00
代理机构 代理人 Dow Kenneth J.
主权项 1. An isolated modified Fc-containing molecule or a fragment thereof comprising a wild type human IgG1 Fc region of SEQ ID NO: 1 comprising a hinge, a CH2 domain and a CH3 domain, wherein a) the sequence of E233-L234-L235-G236 in the hinge is replaced with P233-V234-A235 with G236 deleted; and b) the CH2 domain comprises at least one substitution selected from S239D/1332E, K326A/E333A, H268F/S324T/1332E, F243L/R292P/Y300L, S239D/H268F/S324T/1332E, S267E/H268F/S324T/1332E, K326A/1332E/E333A, S239D/K326A/E333A, S267E/I332E and G237X/S239D/1332E where X is A, D, P, Q or S; wherein amino acid residues are numbered according to EU numbering.
地址 Horsham PA US